The Program for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
The Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Cardiorenal Med. 2023;13(1):9-18. doi: 10.1159/000527390. Epub 2022 Oct 6.
Fluid overload is present in two-thirds of critically ill patients with acute kidney injury and is associated with morbidity, mortality, and increased healthcare resource utilization. Kidney replacement therapy (KRT) is frequently used for net fluid removal (i.e., net ultrafiltration [UFNET]) in patients with severe oliguric acute kidney injury. However, ultrafiltration has considerable risks associated with it, and there is a need for newer technology to perform ultrafiltration safely and to improve outcomes.
Caring for a critically ill patient with oliguric acute kidney injury and fluid overload is one of the most challenging problems. Although diuretics are the first-line treatment for management of fluid overload, diuretic resistance is common. Various clinical practice guidelines support fluid removal using ultrafiltration during KRT. Emerging evidence from observational studies in critically ill patients suggests that both slow and fast rates of net fluid removal during continuous kidney replacement therapy are associated with increased mortality compared with moderate UFNET rates. In addition, fast UFNET rates are associated with an increased risk of cardiac arrhythmias. Randomized trials are required to examine whether moderate UFNET rates are associated with a reduced risk of hemodynamic instability, organ injury, and improved outcomes in critically ill patients. There is a need for newer technology for fluid removal in patients who do not meet traditional criteria for initiation of KRT. Emerging newer and miniaturized ultrafiltration devices may address an unmet clinical need.
Among critically ill patients with acute kidney injury and fluid overload requiring continuous kidney replacement therapy, use of higher and slower UFNET rates compared with moderate UFNET rates might be associated with poor outcomes. Newer minimally invasive technologies may allow for safe and efficient UFNET in patients with acute kidney injury who do not meet criteria for initiation of KRT.
三分之二的伴有急性肾损伤的重症患者存在液体超负荷,并与发病率、死亡率和增加的医疗保健资源利用相关。肾脏替代治疗(KRT)常被用于严重少尿性急性肾损伤患者的净液去除(即净超滤[UFNET])。然而,超滤有相当大的风险,需要新的技术来安全地进行超滤并改善结局。
护理伴有少尿性急性肾损伤和液体超负荷的重症患者是最具挑战性的问题之一。虽然利尿剂是治疗液体超负荷的一线治疗方法,但利尿剂抵抗很常见。各种临床实践指南支持在 KRT 期间使用超滤来去除液体。来自重症患者观察性研究的新证据表明,与适度 UFNET 率相比,连续肾脏替代治疗期间的净液去除的慢和快速率均与死亡率增加相关。此外,快速 UFNET 率与心律失常风险增加相关。需要进行随机试验来检查在重症患者中,适度 UFNET 率是否与降低血流动力学不稳定、器官损伤和改善结局的风险相关。对于不符合开始 KRT 的传统标准的患者,需要新的用于去除液体的技术。新兴的新型和小型化超滤设备可能会满足未满足的临床需求。
在需要连续肾脏替代治疗的伴有急性肾损伤和液体超负荷的重症患者中,与适度 UFNET 率相比,使用更高和更慢的 UFNET 率可能与不良结局相关。新型微创技术可能允许在不符合开始 KRT 标准的急性肾损伤患者中安全有效地进行 UFNET。